Pandya Hetal, Shen Michael J, Ichikawa David M, Sedlock Andrea B, Choi Yong, Johnson Kory R, Kim Gloria, Brown Mason A, Elkahloun Abdel G, Maric Dragan, Sweeney Colin L, Gossa Selamawit, Malech Harry L, McGavern Dorian B, Park John K
National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.
Nat Neurosci. 2017 May;20(5):753-759. doi: 10.1038/nn.4534. Epub 2017 Mar 2.
Microglia are resident inflammatory cells of the CNS and have important roles in development, homeostasis and a variety of neurologic and psychiatric diseases. Difficulties in procuring human microglia have limited their study and hampered the clinical translation of microglia-based treatments shown to be effective in animal disease models. Here we report the differentiation of human induced pluripotent stem cells (iPSC) into microglia-like cells by exposure to defined factors and co-culture with astrocytes. These iPSC-derived microglia have the phenotype, gene expression profile and functional properties of brain-isolated microglia. Murine iPSC-derived microglia generated using a similar protocol have equivalent efficacy to primary brain-isolated microglia in treatment of murine syngeneic intracranial malignant gliomas. The ability to generate human microglia facilitates the further study of this important CNS cell type and raises the possibility of their use in personalized medicine applications.
小胶质细胞是中枢神经系统中的常驻炎症细胞,在发育、内环境稳态以及多种神经和精神疾病中发挥着重要作用。获取人类小胶质细胞的困难限制了对它们的研究,并阻碍了在动物疾病模型中显示有效的基于小胶质细胞的治疗方法的临床转化。在此,我们报告了通过暴露于特定因子并与星形胶质细胞共培养,将人类诱导多能干细胞(iPSC)分化为小胶质样细胞。这些iPSC来源的小胶质细胞具有从大脑中分离出的小胶质细胞的表型、基因表达谱和功能特性。使用类似方案产生的小鼠iPSC来源的小胶质细胞在治疗小鼠同基因颅内恶性胶质瘤方面与原代大脑分离的小胶质细胞具有同等疗效。生成人类小胶质细胞的能力有助于对这种重要的中枢神经系统细胞类型进行进一步研究,并增加了其在个性化医学应用中的使用可能性。